Eyal Desheh
2016
In 2016, Eyal Desheh earned a total compensation of $3.9M as Former Group Executive Vice President and Chief Financial Officer at Teva Pharmaceutical Industries, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $591,775 |
|---|---|
| Option Awards | $1,125,072 |
| Salary | $779,399 |
| Stock Awards | $1,124,934 |
| Other | $269,231 |
| Total | $3,890,411 |
Desheh received $1.1M in option awards, accounting for 29% of the total pay in 2016.
Desheh also received $591.8K in non-equity incentive plan, $779.4K in salary, $1.1M in stock awards and $269.2K in other compensation.
Rankings
In 2016, Eyal Desheh's compensation ranked 2,318th out of 14,075 executives tracked by ExecPay. In other words, Desheh earned more than 83.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,318 out of 14,075 | 84th |
Division Manufacturing | 805 out of 5,489 | 85th |
Major group Chemicals And Allied Products | 237 out of 1,895 | 88th |
Industry group Drugs | 172 out of 1,538 | 89th |
Industry Pharmaceutical Preparations | 134 out of 1,176 | 89th |
Source: SEC filing on April 25, 2018.
Desheh's colleagues
We found three more compensation records of executives who worked with Eyal Desheh at Teva Pharmaceutical Industries in 2016.